GlassScriptPhysician profile
Amol Mehta
NPI 1649775503
$3,019.99
in general payments reported to CMS, 2019-2025
6 companies · $2,703 in 2025
The $2,703 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $317 · 2025: $2,703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,505 · Food and Beverage: $1,361 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,505.46 |
| Food and Beverage | $1,360.54 |
| Education | $153.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,412.55 | 2024-2025 | Surpass Evolve, Target, Trevo |
| Imperative Care, INC | $228.12 | 2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom 4s Catheter |
| Depuy Synthes Sales INC. | $163.46 | 2024 | Embotrap |
| Route 92 Medical, INC. | $150.84 | 2025 | |
| Integra Lifesciences Corporation | $44.85 | 2025 | Codman Hakim, Cusa Clarity, Duraseal Exact Spinal Sealant System |
| Cardiva Medical, INC. | $20.17 | 2025 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amol Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.